Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998810596> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W1998810596 endingPage "A102" @default.
- W1998810596 startingPage "A102" @default.
- W1998810596 abstract "To report efficacy of BG-12 (dimethyl fumarate) in pre-specified patient subgroups stratified by age, gender, treatment history, prior relapses, Expanded Disability Status Score (EDSS), McDonald criteria, T2 lesion volume, and presence/absence of gadolinium-enhancing lesions at baseline in a pre-specified integrated analysis of DEFINE and CONFIRM. This analysis was designed to estimate–more precisely–the treatment effect of BG-12 versus placebo. Eligible patients were aged 18–55 years with a diagnosis of relapsing-remitting multiple sclerosis (RRMS) (McDonald criteria) and an EDSS score of 0–5.0. Patients receiving BG-12 240 mg twice (BID) or three times daily (TID) or placebo were included in this analysis. Primary endpoints were proportion of patients relapsed (DEFINE) and annualized relapse rate (ARR) (CONFIRM) at 2 years. Secondary endpoints included number of new/enlarging T2 lesions and disability progression. The pre-specified integrated analysis was to be conducted only if baseline characteristics and treatment effects were consistent between the studies. The integrated intent-to-treat population comprised 2,301 patients while MRI evaluations were performed in a cohort of 1,046 patients. Baseline characteristics and treatment effects were generally similar across studies. Both BG-12 BID and TID reduced ARR versus placebo at 2 years by approximately 50%, risk of relapse, number of new/enlarging T2 lesions, and risk of disability progression at 2 years versus placebo across the subgroups. For example, ARR versus placebo at 2 years was reduced by 50% (BID; rate ratio 0.50 [95% confidence interval 0.40–0.64]) and 53% (TID; 0.47 [0.37–0.60]) in patients with ≤1 relapse in the year before study entry and 47% (BID; 0.53 [0.40–0.72]) and 41% (TID; 0.59 [0.44–0.80]) in patients with ≥2 relapses. These findings further indicate consistent efficacy of BG-12 on both clinical and neuroradiological measures across a wide spectrum of RRMS patients." @default.
- W1998810596 created "2016-06-24" @default.
- W1998810596 creator A5008598861 @default.
- W1998810596 creator A5008928872 @default.
- W1998810596 creator A5016604378 @default.
- W1998810596 creator A5025462605 @default.
- W1998810596 creator A5046645678 @default.
- W1998810596 creator A5052565461 @default.
- W1998810596 creator A5058311965 @default.
- W1998810596 creator A5062220148 @default.
- W1998810596 creator A5070289069 @default.
- W1998810596 creator A5076296435 @default.
- W1998810596 creator A5077310868 @default.
- W1998810596 date "2013-05-01" @default.
- W1998810596 modified "2023-10-16" @default.
- W1998810596 title "Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS): An integrated analysis of the phase 3 define and confirm studies" @default.
- W1998810596 doi "https://doi.org/10.1016/j.jval.2013.03.481" @default.
- W1998810596 hasPublicationYear "2013" @default.
- W1998810596 type Work @default.
- W1998810596 sameAs 1998810596 @default.
- W1998810596 citedByCount "4" @default.
- W1998810596 countsByYear W19988105962013 @default.
- W1998810596 countsByYear W19988105962014 @default.
- W1998810596 countsByYear W19988105962017 @default.
- W1998810596 crossrefType "journal-article" @default.
- W1998810596 hasAuthorship W1998810596A5008598861 @default.
- W1998810596 hasAuthorship W1998810596A5008928872 @default.
- W1998810596 hasAuthorship W1998810596A5016604378 @default.
- W1998810596 hasAuthorship W1998810596A5025462605 @default.
- W1998810596 hasAuthorship W1998810596A5046645678 @default.
- W1998810596 hasAuthorship W1998810596A5052565461 @default.
- W1998810596 hasAuthorship W1998810596A5058311965 @default.
- W1998810596 hasAuthorship W1998810596A5062220148 @default.
- W1998810596 hasAuthorship W1998810596A5070289069 @default.
- W1998810596 hasAuthorship W1998810596A5076296435 @default.
- W1998810596 hasAuthorship W1998810596A5077310868 @default.
- W1998810596 hasBestOaLocation W19988105961 @default.
- W1998810596 hasConcept C10138342 @default.
- W1998810596 hasConcept C118552586 @default.
- W1998810596 hasConcept C126322002 @default.
- W1998810596 hasConcept C142724271 @default.
- W1998810596 hasConcept C162324750 @default.
- W1998810596 hasConcept C203092338 @default.
- W1998810596 hasConcept C204787440 @default.
- W1998810596 hasConcept C27081682 @default.
- W1998810596 hasConcept C2776819417 @default.
- W1998810596 hasConcept C2780640218 @default.
- W1998810596 hasConcept C2908647359 @default.
- W1998810596 hasConcept C3017619653 @default.
- W1998810596 hasConcept C3020694758 @default.
- W1998810596 hasConcept C44249647 @default.
- W1998810596 hasConcept C535046627 @default.
- W1998810596 hasConcept C71924100 @default.
- W1998810596 hasConcept C72563966 @default.
- W1998810596 hasConcept C99454951 @default.
- W1998810596 hasConceptScore W1998810596C10138342 @default.
- W1998810596 hasConceptScore W1998810596C118552586 @default.
- W1998810596 hasConceptScore W1998810596C126322002 @default.
- W1998810596 hasConceptScore W1998810596C142724271 @default.
- W1998810596 hasConceptScore W1998810596C162324750 @default.
- W1998810596 hasConceptScore W1998810596C203092338 @default.
- W1998810596 hasConceptScore W1998810596C204787440 @default.
- W1998810596 hasConceptScore W1998810596C27081682 @default.
- W1998810596 hasConceptScore W1998810596C2776819417 @default.
- W1998810596 hasConceptScore W1998810596C2780640218 @default.
- W1998810596 hasConceptScore W1998810596C2908647359 @default.
- W1998810596 hasConceptScore W1998810596C3017619653 @default.
- W1998810596 hasConceptScore W1998810596C3020694758 @default.
- W1998810596 hasConceptScore W1998810596C44249647 @default.
- W1998810596 hasConceptScore W1998810596C535046627 @default.
- W1998810596 hasConceptScore W1998810596C71924100 @default.
- W1998810596 hasConceptScore W1998810596C72563966 @default.
- W1998810596 hasConceptScore W1998810596C99454951 @default.
- W1998810596 hasIssue "3" @default.
- W1998810596 hasLocation W19988105961 @default.
- W1998810596 hasOpenAccess W1998810596 @default.
- W1998810596 hasPrimaryLocation W19988105961 @default.
- W1998810596 hasRelatedWork W2000550165 @default.
- W1998810596 hasRelatedWork W2040417878 @default.
- W1998810596 hasRelatedWork W2093009907 @default.
- W1998810596 hasRelatedWork W4212920103 @default.
- W1998810596 hasRelatedWork W4229906470 @default.
- W1998810596 hasRelatedWork W4311497153 @default.
- W1998810596 hasRelatedWork W2592676331 @default.
- W1998810596 hasRelatedWork W2625199698 @default.
- W1998810596 hasRelatedWork W2744932000 @default.
- W1998810596 hasRelatedWork W633612142 @default.
- W1998810596 hasVolume "16" @default.
- W1998810596 isParatext "false" @default.
- W1998810596 isRetracted "false" @default.
- W1998810596 magId "1998810596" @default.
- W1998810596 workType "article" @default.